New Medicines for Bacterial Infections and Cancers
Bioorganic Approaches Toward Novel Antimicrobial Agents and Chemotherapeutics
This work aims to create new chemical tools and medicines to better understand and treat serious conditions like bacterial infections and cancers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project ID | NIH-11087606 on NIH RePORTER |
What this research studies
Our laboratory combines advanced chemistry with important biological questions to develop new molecular tools. We focus on creating robust chemical reactions and synthesis strategies to address clinically relevant diseases. By developing these new molecules, we hope to gain a deeper understanding of human diseases. This foundational work could lead to new ways to fight drug-resistant bacteria and various types of cancer. Our vision is to apply a human health-driven approach to these challenging problems.
Who could benefit from this research
Good fit: Patients suffering from bacterial infections, especially those resistant to current treatments, or various forms of cancer, could potentially benefit from future therapies developed from this foundational work.
Not a fit: Patients whose conditions are not related to bacterial infections or cancer, or those who do not require new chemical therapies, may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this research could lead to the discovery of entirely new types of medicines to combat difficult-to-treat bacterial infections and various cancers.
How similar studies have performed: This research focuses on novel bioorganic chemistry approaches, which are foundational and aim to discover new chemical entities, rather than building on previously successful similar drug candidates.
Where this research is happening
Nashville, UNITED STATES
- Vanderbilt University — Nashville, United States (Active)
Researchers
- Principal investigator: Townsend, Steven D. — Vanderbilt University
- Study coordinator: Townsend, Steven D.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.